Immunodiagnosis of tuberculosis in HIV-infected adults in settings of high HIV/tuberculosis burden

European Respiratory Disease

Volumn 8, Issue 2, 2012, Pages 148-153

  Oni, Tolu ^a,b   Wilkinson, Robert J ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Diagnostics; HIV; Immunology; Tuberculosis

Indexed keywords

EID: 84869998956     PISSN: 17545552     EISSN: 17545560     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dye C, Global epidemiology of tuberculosis, The Lancet,2006;367(9514):938-40.
2. Lopez AD, Mathers CD, Measuring the global burden of disease and epidemiological transitions: 2002-2030, Ann Trop Med Parasitol, 2006;100(5):481-99.
3. Lawn SD, Wood R, Wilkinson RJ, Changing concepts of 'latent tuberculosis infection' in patients living with HIV infection, Clin Dev Immunol, 2011;2011:1-9.
4. Young DB, Gideon HP, Wilkinson RJ, Eliminating latent tuberculosis, Trends Microbiol, 2009;17(5):183-8.
5. Pai M, Riley LW, Colford JM Jr, Interferon-? assays in the immunodiagnosis of tuberculosis: a systematic review, Lancet Infect Dis, 2004;4(12):761-76.
6. Dodd LE, Wilkinson RJ, Isoniazid preventive therapy in HIV infection, The Lancet, 2011;377(9777):1548-50.
7. Angeby KA, Alvarado-Gálvez C, Pineda-García L, Hoffner SE, Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis, Int J Tuberc Lung Dis, 2000;4(7):684-7.
8. Abebe F, Holm-Hansen C, Wiker HG, Bjune G, Progress in serodiagnosis of Mycobacterium tuberculosis infection, Scand J Immunol, 2007;66(2-3):176-91.
9. Pottumarthy S, Wells VC, Morris AJ, A comparison of seven tests for serological diagnosis of tuberculosis, J Clin Microbiol, 2000;38(6):2227-31.
10. Steingart KR, Flores LL, Dendukuri N, et al., Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis, Plos Med, 2011;8(8):e1001062
11. Dowdy DW, Steingart KR, Pai M, Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis, Plos Med, 2011;8(8):e1001074.
12. WHO, Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement, Geneva: World Health Organization,2011;1-19.
13. Minion J, Leung E, Talbot E, et al., Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis, Eur Respir J, 2011:38;1398-405.
14. Shah M, Martinson NA, Chaisson RE, et al., Quantitative analysis of a urine-based assay for detection of lipoarab inomannan in patients with tuberculosis, J Clin Microbiol, 2010;48(8):2972-4.
15. Shah M, Variava E, Holmes CB, et al., Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting, J Acquir Immune Defic Syndr, 2009;52(2):145-51.
16. Reither K, Saathoff E, Jung J, et al., Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis, BMC Infect Dis, 2009;9(1):141.
17. Mutetwa R, Boehme CC, Dimairo M, et al., Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients, Int J Tuberc Lung Dis, 2009;13(10):1253-9.
18. Gounder CR, Kufa T, Wada NI, et al. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis, J Acquir Immune Defic Syndr, 2011;58(2):219-23.
19. Samandari T, Agizew TB, Nyirenda S, et al., 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial, The Lancet, 20 11;377(9777):1588-98.
20. Chapman A, Munkanta M, Wilkinson K, et al., Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells, AIDS, 2002;16(17):2285-93.
21. Leidl L, Mayanja-Kizza H, Sotgiu G, et al., Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection, Eur Respir J, 2010;35(3):619-26.
22. Rangaka MX, Wilkinson KA, Seldon R, et al., Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection, Am J Respir Crit Care Med, 2006;175(5):514-20.
23. Aabye MG, Ravn P, PrayGod G, et al., The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis, PLoS ONE, 2009;4(1):e4220.
24. Karam F, Mbow F, Fletcher H, et al., Sensitivity of IFN-? release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE, 2008;3(1):e1441.
25. Lawn SD, Bangani N, Vogt M, et al., Utility of interferon-? ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa, BMC Infect Dis, 2007;7(1):99.
26. Diel R, Loddenkemper R, Nienhaus A, Evidence-based comparison of commercial interferon- release assays for detecting active TB: a metaanalysis, Chest, 2010;137(4):952-68.
27. Sester M, Sotgiu G, Lange C, et al., Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis, Eur Respir J, 2010;37(1):100-11.
28. Raby E, Moyo M, Devendra A, et al., The effects of HIV on the sensitivity of a whole blood IFN-? release assay in Zambian adults with active tuberculosis, PLoS ONE, 2008;3(6):e2489.
29. Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, et al., Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals, PLoS ONE, 2009;4(5):e5718.
30. Tsiouris SJ, Coetzee D, Toro PL, et al., Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis, J Clin Microbiol, 2006;44(8):2844-50.
31. Rangaka MX, Gideon HP, Wilkinson KA, et al., Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms, Eur Respir J, 2012;39:163-171.
32. Dheda K, Smit RVZ, Badri M, Pai M, T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs low-burden settings, Curr Opin Pulm Med, 2009;15(3):188-200.
33. Oni T, Patel J, Gideon HP, et al., Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts, Eur Respir J, 2010;36(3):594-600.
34. Chegou NN, Walzl G, Bolliger CT, et al., Evaluation of adapted whole-blood interferon-gamma; release assays for the diagnosis of pleural tuberculosis, Respiration, 2008;76(2):131-8.
35. Baba K, Sørnes S, Hoosen AA, et al., Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON® TB-Gold interferon-gamma assay, BMC Infect Dis, 2008;8(1):35.
36. Thomas MM, Hinks TSC, Raghuraman S, et al., Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells, Int J Tuberc Lung Dis, 2008;12(6):651-7.
37. Patel VB, Singh R, Connolly C, et al., Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population, Am J Respir Crit Care Med, 2010;182(4):569-77.
38. Mandalakas AM, Hesseling AC, Chegou NN, et al., High level of discordant IGRA results in HIV-infected adults and children, Int J Tuberc Lung Dis, 2008;12(4):417-23.
39. Cattamanchi A, Smith R, Steingart KR, et al., Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis, J Acquir Immune Defic Syndr, 2011;56(3):230-8.
40. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M, Within-subject variability of interferon-? assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review, PLoS ONE, 2009;4(12):e8517.
41. Pai M, Joshi R, Dogra S, et al., T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India, Int J Tuberc Lung Dis, 2009;13(1):84-92.
42. Shanaube K, de Haas P, Schaap A, et al., Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia, Int J Tuberc Lung Dis, 2010;14(7):828-33.
43. Hill PC, Jackson Sillah DJ, Fox A, et al., Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts, PLoS ONE, 2008;3(1):e1379.
44. Markowitz N, Hansen NI, Hopewell PC, et al., Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group, Ann Intern Med, 1997;126(2):123-32.
45. Antonucci G, Girardi E, Raviglione MC, Ippolito G, Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA), JAMA,1995;274(2):143-8.
46. Rangaka MX, Wilkinson KA, Glynn JR, et al., Predictive value of interferon-? release assays for incident active tuberculosis: a systematic review and meta-analysis, Lancet Infectious Diseases, 2011;4:761-6.